| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.05 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.06 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.083 | 0.06 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |